Science & Technology Fund
Data updated: 2025-04-28
C000027161 — Science & Technology Fund. United States Large Cap Growth Information Technology Equity. Holdings, fees, performance and SEC filings.
C000027161 Fund Overview
Science & Technology Fund is a US mutual fund managed by John Hancock Funds II, categorised as United States Large Cap Growth Information Technology Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: John Hancock Funds II
- Category: United States Large Cap Growth Information Technology Equity
- Assets under management: $72.83M
- 1-year return: 14.2%
- SEC CIK: 0001331971
- SEC series ID: S000009815
- Share class ID: C000027161
C000027161 Investment Objective and Strategy
Science & Technology Fund describes its objective and strategy as follows, from its latest prospectus filed with the SEC by John Hancock Funds II.
Investment objective
To seek long-term growth of capital. Current income is incidental to the fund's objective.
Principal investment strategy
"Under normal market conditions, the fund invests at least 80% of its net assets (plus any borrowings for investment purposes) in the common stocks of companies expected to benefit from the development, advancement, and/or use of science and technology. For purposes of satisfying this requirement, common stock may include equity-linked notes and derivatives relating to common stocks, such as options on equity-linked notes. The fund employs a multi-manager approach with two managers, each of which employs its own investment approach and independently manages its portion of the fund. The fund will be rebalanced periodically so that the managers manage the following portions of the fund: 50%* Allianz Global Investors U.S. LLC (""AllianzGI US"") 50%* T. Rowe Price Associates, Inc. (""T. Rowe Price"") *Percentages are approximate.
Since the fund is only rebalanced periodically, the actual portion of the fund managed by each manager will vary. This allocation methodology may change in the future. Some industries likely to be represented in the fund include: information technology including hardware, software, semiconductors and technology equipment telecommunications equipment and services media including advertising, broadcasting, cable and satellite, movies, entertainment, publishing and information services environmental services internet commerce and advertising life sciences and health care, including pharmaceuticals, health care equipment and services, and biotechnology chemicals and synthetic materials defense and aerospace alternative energy While most of the fund's assets are invested in U.S. common stocks, the fund may also purchase other types of securities, including U.S.
dollar- and foreign currency-denominated foreign securities, convertible stocks and bonds, and warrants, and use futures and options, in keeping with the fund's investment objective. Stock selection for the fund generally reflects a growth approach based on an assessment of a company's fundamental prospects for above-average earnings, rather than on a company's size. As a result, fund holdings can range from securities of small companies developing new technologies to securities of blue chip firms with established track records. The fund may also invest in companies that are expected to benefit from technological advances even if they are not directly involved in research and development. The fund may invest in technology companies through initial public offerings (IPOs). The fund holds a certain portion of its assets in money market reserves, which can consist of shares of the T.
Rowe Price Government Reserve Fund (or any other internal T. Rowe Price money market fund) as well as U.S. dollar- and foreign currency-denominated money market securities, including repurchase agreements, in the two highest rating categories, maturing in one year or less. The fund may invest reserves in U.S. dollars and foreign currencies. The fund may sell securities for a variety of reasons such as to secure gains, limit losses or redeploy assets into more promising opportunities. The fund may invest up to 10% of its total assets in hybrid instruments. Hybrid instruments are a type of high-risk derivative which can combine the characteristics of securities, futures and options. Such securities may bear interest or pay dividends at below market (or even relatively nominal) rates. In managing its portion of the fund, AllianzGI US may enter into short sales including short sales against the box.
In pursuing the fund's investment objective, each manager has the discretion to purchase some securities that do not meet its normal investment criteria, as described above, when they perceive an unusual opportunity for gain. These special situations might arise when a manager believes a security could increase in value for a variety of reasons including a change in management, an extraordinary corporate event, a new product introduction or innovation, or a favorable competitive development. The fund's investment process may, at times, result in a higher-than-average portfolio turnover ratio and increased trading expenses."
C000027161 Holdings
Top 10 holdings of Science & Technology Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Apple Inc. | 9.60% |
| Meta Platforms Inc. | 9.40% |
| Microsoft Corporation | 7.23% |
| NVIDIA Corporation | 6.91% |
| Broadcom Inc. | 5.85% |
| Alphabet Inc. | 3.84% |
| Alphabet Inc. | 3.72% |
| Cisco Systems Inc. | 2.93% |
| Oracle Corporation | 2.31% |
| Salesforce Inc. | 2.20% |
C000027161 Portfolio Allocation
Asset-class allocation of Science & Technology Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.9% |
| Cash & Equivalents | 0.1% |
C000027161 Performance
Total returns for C000027161 (as of 2026-10-01), from SEC filings.
| Period | Total return |
|---|---|
| 1 year | 14.2% |
| 3 years (annualised) | 15.2% |
| 5 years (annualised) | 17.7% |
C000027161 Risk Information
Risk metrics for C000027161, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 16.7%
C000027161 Costs and Fees
C000027161 costs about $104 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.04%
- Gross expense ratio: 1.05%
- Portfolio turnover: 297%
- Brokerage commissions: 9.11 bps of average net assets (SEC N-CEN)
C000027161 Cashflows
Over the 12 months to 2025-02, Science & Technology Fund had net outflows of $142.73M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2025-02 | −$66.91M |
| 2025-01 | −$27.17M |
| 2024-12 | $12.29M |
| 2024-11 | −$4.95M |
| 2024-10 | −$6.29M |
| 2024-09 | −$2.18M |
C000027161 Debt Constituents
No individual debt constituents are reported in Science & Technology Fund's latest SEC N-PORT filing.
C000027161 Prospectus and SEC Filings
Official Science & Technology Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2024-12-20
- Prospectus (485BPOS) — filed 2023-12-21
- Prospectus (485BPOS) — filed 2022-12-23
- Portfolio holdings (N-PORT) — filed 2025-04-28
- Portfolio holdings (N-PORT) — filed 2025-01-28
- Portfolio holdings (N-PORT) — filed 2024-10-29
- Annual census (N-CEN) — filed 2024-11-13
- Annual census (N-CEN) — filed 2023-11-08
Related Funds
Other United States Large Cap Growth Information Technology Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.